-+ 0.00%
-+ 0.00%
-+ 0.00%

*Caribou Biosciences: Cash, Cash Equivalents, and Marketable Securities Sufficient to Fund Operating Plan Into 2H 2027 >CRBU

Dow Jones·11/12/2025 21:21:00

Please log in to view news